Literature DB >> 19642032

[Cryptogenic infarct. A follow-up period of 1 year study].

E Palomeras Soler1, P Fossas Felip, A T Cano Orgaz, P Sanz Cartagena.   

Abstract

OBJECTIVE: To analyze the outcome of patients with a cryptogenic infarct (CI) after a follow-up period of 1 year.
METHODS: From our prospective registry of stroke, during a 4-year period, we've identified 121 consecutive patients with a CI (15.1% of all infarcts). They have been followed up for 1 year and we have registered stroke recurrence, cardiovascular events and other incidences.
RESULTS: Mean age 70.6 years-old, 53% male. Middle cerebral artery (MCA) was the most often involved territory (52 cases), 70% of them with cortical involvement. No patient died during admission, 95.8% received antiplatelet therapy and 4.1% oral anticoagulant. Fourteen patients were lost of follow-up. During 1-year period, atrial fibrillation (AF) was detected in 7 patients (6.54%), their mean age was 75 years-old, in 5 of them the CI was in MCA territory (4 with cortical involvement, 1 only deep infarct). Three patients (2.76%) suffered a recurrent ischemic stroke, in weeks 15, 16 and 44 after the CI. In all 3 cases the infarct was considered cryptogenic again. Two patients suffered a myocardial infarction and 4 died during follow-up period.
CONCLUSION: In our series rate of stroke recurrence and cardiovascular events after a CI was low. An 11% of patients with a CI involving cortical MCA territory developed FA during the following year.

Entities:  

Mesh:

Year:  2009        PMID: 19642032

Source DB:  PubMed          Journal:  Neurologia        ISSN: 0213-4853            Impact factor:   3.109


  2 in total

1.  Epidemiology and risk factors of cerebral ischemia and ischemic heart diseases: similarities and differences.

Authors:  Ernest Palomeras Soler; Virgina Casado Ruiz
Journal:  Curr Cardiol Rev       Date:  2010-08

2.  The mystery of recurrent idiopathic cerebrovascular and coronary arterial thrombosis.

Authors:  Ali Raza Rajani; Wael Ezzat Mahmoud; Vagishwari Murugesan; Azan Salem BinBrek
Journal:  BMJ Case Rep       Date:  2014-11-24
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.